Ambulatory/home cares development and oral drugs dispensation at home for the treatment and the management of serious diseases are the major orientation of healthcare system worldwide. In this context, adaptation of prescribed dose in real time and the prevention of the dispensation errors are a challenge especially for oral drugs which are complex in terms of scheme of administration, need a close monitoring of adverse events, a prevention of complications and a management of adherence.
In this situation, patient and healthcare professionals (hospital sector and ambulatory sector) need an efficient information system for an optimal organisation of cares and for an appropriate patients’ telesurveillance, checking adherence to the treatment and early alerting of adverse events or complications.
To cover this need and meet such evolution, the company is developing a smart connected dispensing device that guarantees the security and the data Track of the packaging of pharmaceutical products and connects patients continuously to healthcare professionals in real time, while ensuring in real time the correct dispensation of their prescribed oral doses in a secure way at home.
The application of the offer could be tailored for any diseases treated with oral drugs in at risk patients population who need scrutiny.
At the moment, experiments are led in oncology in 2 centers in France with the first inclusion of patient in May 2020. The patient-centered approaches applied to the development of the remote-care software are positive for the patients and are communicated in a poster during a conference in psycho-oncology in November 2019.
The offer is adaptable: it could be the connected dispensing device and secured packaging alone associated with a remote-care software developed by a partner or a remote-care software alone for the digital coordination of cares and patients reported outcomes (treatment adherence included) or both of them.
The partnership could be with:
- healthcare institutions which have the project to implement digital organisation of cares and patients’ drugs telesurveillance,
- others SMEs which want to integrate remote-care sofware technologie or connected device with their apps to monitor adherence to drug and surveillance of patients,
- pharma companies in the frame of their randomized clinical trials or of their study in real life conditions for oral drugs which need specific safety monitoring.
The company is interested in technical cooperation agreement, research cooperation agreement or commercial agreement with technical assistance.
